Management of Patients Who Cannot Receive Anticoagulants
For patients with venous thromboembolism (VTE) who have absolute contraindications to anticoagulation, placement of an inferior vena cava (IVC) filter is recommended, with prompt removal once anticoagulation can be safely resumed. 1, 2
Absolute Contraindications to Anticoagulation
The following situations warrant withholding anticoagulation 1:
- Active bleeding (any site)
- Recent intracranial hemorrhage
- Recent, planned, or emergent surgery with high bleeding risk
- Severe thrombocytopenia (platelet count <50,000/mL)
- Severe bleeding diathesis
Management Algorithm
Step 1: Confirm True Contraindication
Not all bleeding concerns justify withholding anticoagulation. The following are NOT absolute contraindications 1:
- Peptic ulcer disease without active bleeding
- Guaiac-positive stools alone
- Most trauma/neurosurgical patients after 1-2 weeks postoperatively
- Stroke patients without intracranial hemorrhage
- Spinal cord injury without hematomyelia
Step 2: IVC Filter Placement
For acute VTE (diagnosed within the preceding month) with confirmed contraindication to anticoagulation:
- Place a retrievable IVC filter 2
- This is the only strong indication for filter placement
- Filters reduce early PE risk but increase DVT risk long-term
- Do NOT place filters in anticoagulated patients, even with severe PE (insufficient evidence of benefit) 2
Step 3: Monitoring and Filter Removal
Critical implementation points:
- Establish a systematic tracking system to monitor all patients with IVC filters 2
- Schedule regular reassessment for filter removal eligibility
- Remove filter promptly once anticoagulation can be initiated 2
- Many filters remain in place inappropriately—active surveillance prevents this complication
Step 4: Initiate Anticoagulation When Safe
Once the contraindication resolves:
- Start anticoagulation immediately
- For most patients: Low-molecular-weight heparin (LMWH) followed by vitamin K antagonists targeting INR 2.0-3.0 3
- Avoid unfractionated heparin due to high risk (15-28%) of heparin-induced thrombocytopenia in this population 3
- Direct oral anticoagulants (DOACs) may be considered if liver function is preserved 3
Special Considerations for Specific Conditions
Budd-Chiari Syndrome (BCS)
If the patient has hepatic vein thrombosis and cannot receive anticoagulation 3:
- Percutaneous transluminal balloon angioplasty for short-segment stenoses (first-line mechanical intervention)
- Transjugular intrahepatic portosystemic shunt (TIPS) if angioplasty fails or is not feasible
- Emergency TIPS with simultaneous liver transplant listing for acute liver failure
- Ensure variceal prophylaxis is in place before starting anticoagulation when contraindication resolves
Pregnancy
- Same indications for IVC filter as non-pregnant patients 1
- Warfarin is contraindicated due to teratogenicity
- Use LMWH when anticoagulation becomes feasible
Common Pitfalls to Avoid
Overuse of IVC filters: Filters are frequently placed inappropriately, especially in the United States. Only use for acute VTE with true contraindications 2
Failure to remove retrievable filters: Many filters remain permanently despite resolution of contraindication. Implement institutional tracking systems 2
Confusing relative with absolute contraindications: Elderly patients, fall risk, and compliance concerns are relative contraindications—consider individualized risk-benefit, but these alone don't mandate filter placement 1
Placing filters as adjunct to anticoagulation: The PREPIC2 trial showed no benefit to adding filters in anticoagulated patients 2
Using unfractionated heparin in BCS: This population has unusually high rates of heparin-induced thrombocytopenia (15-28%) 3
Timing of Anticoagulation Resumption After Bleeding
When the contraindication was bleeding 4:
- Delay restart if bleeding occurred at critical site, high rebleeding risk, source unidentified, or surgery planned
- Restart anticoagulation once patient is stable and above factors don't apply
- For most patients, resuming between 7-15 days after bleeding event appears safe 5